1 p.m. Monday, September 18
Drug companies have spent billions of dollars on it. Academics have devoted decades to it. So where are the new drugs for Alzheimer’s disease?
STAT reporters Sharon Begley and Damian Garde will moderate a chat with Dr. Reisa Sperling of Brigham and Women’s Hospital — one of the world’s leading experts on Alzheimer’s disease — to answer just that.